Clinical Trial

Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)

Study acronym: ACCESS-T1D
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to identify people with T1D or celiac disease (CD) early in the course of their disease and to improve the methods of screening for these diseases.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06 -> 2026-12 2026-08-13
minor Completion pushed: 2026-06 -> 2026-12 2026-08-13
Trial Details
NCT Number NCT06908057
Lead Sponsor AdventHealth Translational Research Institute
Conditions Type 1 Diabetes, Celiac Disease
Enrollment 115 participants
Start Date 2024-03-11
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-12